State of the Stack

Combining those two substances appears to boost their effects on me. It's surprising nobody else has noticed what a profitable item a pre-mixed version could turn into for sellers.

Mixing substances together isn't often worthwhile, and that particular compound doesn't live up to the hype. Its brief time in circulation along with the unstable nature of the molecule lead me to pass on it.

Some research points to oxytocin lowering hunger levels across both people and lab animals. Trying it myself gave similar results. Because it takes time to absorb after an injection under the skin the effective duration ends up extended since the compound enters circulation bit by bit. Nearly every peptide faces this issue of very brief time in the blood unless it has been altered to persist like certain GLP compounds. Research often looks at nasal dosing several times daily. I question whether these compounds can travel straight into the brain via the nose in people since the distance for diffusion is far greater than in smaller creatures and measuring levels inside the human brain is not straightforward. The substance still enters the bloodstream through nasal tissue and from there it may or may not cross into the brain.

Goddamn

I appreciate you taking the time to post your own thoughts here. It really helps balance out all the mixed-up stories coming from video sites that keep overwhelming us.

I switched my Epithalion amount from the earlier 50ML at 5mg level up to 1ml at 10mg, and the strong dreams came back right away. Once more I got out of bed feeling quite rested. I plan to repeat the 10mg amount again this evening. For the oxytocin I mixed 10mg into 25ML of saline inside a nasal spray container. Beforehand I checked the weight of a filled bottle, pressed the pump ten times, and checked the weight again so I could work out the proper 1-2 sprays per nostril, meaning 2-4 sprays total each time and roughly 112-224mcg or 56-112 IU per use. I noticed a sense of calm, yet nothing like feeling more connected to others. I will keep trying it over the coming two weeks to check whether anything else shows up or if any clear changes appear.

Last night I injected another milliliter equaling ten milligrams under the skin prior to sleeping. Once more I experienced intense dreaming and remained asleep for ten hours, waking up quite revitalized. It appears ten milligrams works best for me at this point. With several days remaining I plan to keep taking the same amount.

Curious about the Epi amounts people have been using lately. Saw a discussion recently suggesting the recommended levels could turn out lower than earlier ideas indicated.

I tested smaller amounts of the two substances together each day across six days. Everything felt fine and my seasonal allergies disappeared entirely for three months afterward. That lines up with how immune responses work. With no bad reactions showing up I plan to try the complete version at higher daily amounts for ten days once my next supply arrives. Human studies support using that amount safely in a yearly short course. Solid trial results like this don't come along often. Individual accounts suggest it can be repeated twice within one year. The underlying research indicated these compounds fit best with occasional short courses rather than ongoing daily intake.

Although some tests involving people have occurred with these peptides, describing the safety information as solid overdoes it. This still beats the situation for lots of other peptides that lack any human checks at all. Even though the studies come from Russia, just like those on bioregulators along with certain other peptides, that alone doesn't make the work poor. Yet without any replication from elsewhere, there's good reason for doubt. It's unfortunate that money often pushes folks to hype the research. They frequently blend results from non-human sources with human ones, making it seem like human data when it isn't, and they omit how preliminary work rarely translates, with most candidates failing later on. An accuracy-focused summary generated by the AI tool notes only minor human trials, mainly Russian in source. The proof level doesn't meet today's trial criteria. The brief dosing cycle hasn't been checked in careful studies. Safety details remain thin rather than strong.